Drug Type Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism NTSR1 antagonists(Neurotensin receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal Neoplasms | Preclinical | CN | 23 Jan 2024 | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | CN | 23 Jan 2024 |